Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
198.70    -3.90 (-1.92%)
Bid:
198.70
Ask:
199.00
Spread: 0.30 (0.151%)
Market Cap: £1.29b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Apr 2026 07:00

RNS Number : 6500A
Ashmore Group PLC
16 April 2026
 

Ashmore Group plc 16 April 2026

THIRD QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc (Ashmore, the Group), the specialist Emerging Markets asset manager, announces the following update to its assets under management (AuM) in respect of the quarter ending 31 March 2026.

Assets under management

Investment theme

Actual31 December 2025

(US$ billion)

Estimated31 March 2026

(US$ billion)

- External debt

8.4

8.0

- Local currency

15.7

16.4

- Corporate debt

5.3

5.1

- Blended debt

12.5

10.5

Fixed income

41.9

40.0

Equities

8.8

8.8

Alternatives

1.8

1.9

Total

52.5

50.7

 

AuM decreased by US$1.8 billion (-3%) over the period, comprising negative investment performance of US$0.9 billion and net outflows of US$0.9 billion. Positive momentum from 2025, supported by macro fundamentals and an ongoing capital rotation into emerging markets, continued into the period but was interrupted by the broadening of the conflict in the Middle East at the end of February. This resulted in heightened global market volatility and a "wait and see" approach being adopted by some investors.

Subscription activity remained healthy relative to recent period averages, delivering a net inflow in both local currency and equities. However, an institutional redemption from the blended debt theme meant there was a net outflow from blended debt as well as a small net outflow from external debt.

Emerging markets indices were flat to down 3% over the quarter, with strong performance in January and February followed by weaker global markets in March. Active investment management is critical to navigating such periods of market volatility and Ashmore continues to deliver outperformance for clients across its equity and fixed income strategies. Compared with 31 December, the proportion of Group AuM outperforming benchmark indices is consistent in the near to mid-term and has improved over the longer term.

 

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Geopolitical events interrupted some of the macro tailwinds supporting emerging markets, but the reaction across most asset classes has so far been manageable and with limited price dislocations. In the near term, investors globally are taking a more measured stance until there is greater clarity in the outlook for the duration of the conflict and its implications for factors such as commodity prices, inflation, interest rates and currency trends.

"As ever, it is paramount to understand the rich diversity of emerging markets and therefore to manage portfolios actively to deliver investment performance. Ashmore's specialist approach and long history of investing in emerging markets, across different cycles and complex geopolitical and macro events, means it is well positioned to navigate the current environment.

"At the end of the period, Ashmore was delighted to announce the establishment of a strategic partnership with Japan Post Insurance Co., Ltd. This new strategic partnership builds on a strong existing relationship in order to capitalise on the growth opportunity across a broad range of attractive emerging market asset classes."

 

Notes

Local currency AuM includes US$8.9 billion of AuM managed in overlay/liquidity strategies (31 December 2025: US$8.5 billion).

 

For further information please contact:

Ashmore Group plc Paul Measday +44 (0)20 3077 6278Jordan Griffin +44 (0)20 3077 6385 ir@ashmoregroup.com

Cardew Group Tom Allison +44 (0)7789 998020Will Baldwin-Charles +44 (0)7834 524833 ashmore@cardewgroup.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIDSRIELIR
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.